塔克-KGC:基于张量分解的糖尿病知识图完成模型,整合了中国和西方医学
Jiangtao ZhangSun1, Yu Xin Yang1, Beiji Zou2
1School of Informatics, Hunan University of Chinese Medicine, Changsha, Hunan, China.
PeerJ. Computer science
|March 10, 2025
概括
本研究介绍了塔克分解知识图完成 (Tuck-KGC) 方法,通过结合实体类型来改进医学知识图. 这种方法提高了链接预测准确度,以获得更好的智能医疗服务.
科学领域:
- 医疗信息学 医疗信息学
- 人工智能的人工智能
- 生物医学数据科学 生物医学数据科学
背景情况:
- 医学知识图表对于先进的医疗应用,如个性化诊断和治疗,至关重要.
- 由于缺少实体或关系,医疗知识图的不完整性阻碍了它们的有效性.
- 现有的知识图完成的张量分解方法往往忽略了重要的实体类型信息,导致不准确的预测.
研究的目的:
- 解决医学知识图表中不完整和不准确的问题.
- 提出一种新的方法,塔克分解知识图完成 (Tuck-KGC),集成实体类型信息.
- 为了提高医学知识图表中链接预测的准确性.
主要方法:
- 开发了塔克分解知识图完成 (Tuck-KGC) 模型.
- 纳入的医疗实体类型通过将类型映射到向量,进入张量分解框架.
- 将这些类型向量集成到知识图表表示学习过程中.
- 创建了Dia数据集,这是一个用于精确分析的全面医学知识图表.
主要成果:
- 塔克-KGC模型证明了链接预测准确度的提高.
- 实验结果显示,与基线方法相比,链接预测准确度大约增加了8%.
- 纳入实体类型信息显著提高了模型预测准确关系的能力.
结论:
- 塔克-KGC方法有效地利用实体类型信息来改善医学知识图表的完成.
- 整合实体类型可以提高预测关系的准确性和可靠性,这对于智能医疗服务至关重要.
- 迪亚数据集为评估和推进医学知识图表研究提供了宝贵的资源.
相关概念视频
Diabetes Mellitus: Overview and Type I Subtype
2.3K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
2.3K
Diabetes Mellitus: Type 2 and Gestational
2.1K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
2.1K
Combination Therapies and Personalized Medicine
4.8K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.8K
Diabetes: Management and Pharmacotherapy
222
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
222


